Peyronies Disease Treatment market size was valued at $1.16 billion in 2026, projected to reach $1.73 billion by 2030 at a 10.5% CAGR. Key players: Keenova Therapeutics plc, Coloplast A/S, Boston Scientific Corporation.
The Betulinic Acid market size is expected to reach $2.69 billion in 2030 at a CAGR of 13.2%, driven by increasing pharmaceutical drug discovery R&D spending.
Postbiotic Ingredient market to reach $2.02 billion by 2030 at 11.1% CAGR, driven by rising demand for preventive healthcare and immune health support products.
Pleural Effusion Drug market to reach $5.31 billion by 2030 at 9.9% CAGR, driven by growing cardiovascular disease burden and healthcare expenditure.
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.